Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Carrizosa Anderson

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Current Opinion in Immunology|January 10, 2012
Tim-3, a negative regulator of anti-tumor immunityAna Carrizosa Anderson
Journal for Immunotherapy of Cancer|July 9, 2025
Therapeutic potential of targeting LAG-3 in cancerDiwakar Davar, Ana Carrizosa Anderson, Ivan Diaz-Padilla
Journal for Immunotherapy of Cancer|July 1, 2020
Tim-3 finds its place in the cancer immunotherapy landscapeNandini Acharya, Catherine Sabatos-Peyton, Ana Carrizosa Anderson
Frontiers in Immunology|November 12, 2015
The Non-Obese Diabetic Mouse Strain as a Model to Study CD8(+) T Cell Function in Relapsing and Progressive Multiple SclerosisPrenitha Mercy Ignatius Arokia Doss, Andrée-Pascale Roy, AiLi Wang, et al.
Frontiers in Immunology|February 4, 2020
Endogenous T Cell Receptor Rearrangement Represses Aggressive Central Nervous System Autoimmunity in a TcR-Transgenic Model on the Non-Obese Diabetic BackgroundAsmita Pradeep Yeola, Prenitha Mercy Ignatius Arokia Doss, Joanie Baillargeon, et al.
Journal for Immunotherapy of Cancer|June 20, 2024
Challenges and opportunities in cancer immunotherapy: a Society for Immunotherapy of Cancer (SITC) strategic visionLeisha A Emens, Pedro J Romero, Ana Carrizosa Anderson, et al.
Journal of Translational Medicine|October 29, 2014
Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013Paolo A Ascierto, Antonio M Grimaldi, Ana Carrizosa Anderson, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Opinion in Immunology|January 10, 2012
Tim-3, a negative regulator of anti-tumor immunityAna Carrizosa Anderson
Journal for Immunotherapy of Cancer|July 9, 2025
Therapeutic potential of targeting LAG-3 in cancerDiwakar Davar, Ana Carrizosa Anderson, Ivan Diaz-Padilla
Journal for Immunotherapy of Cancer|July 1, 2020
Tim-3 finds its place in the cancer immunotherapy landscapeNandini Acharya, Catherine Sabatos-Peyton, Ana Carrizosa Anderson
Frontiers in Immunology|November 12, 2015
The Non-Obese Diabetic Mouse Strain as a Model to Study CD8(+) T Cell Function in Relapsing and Progressive Multiple SclerosisPrenitha Mercy Ignatius Arokia Doss, Andrée-Pascale Roy, AiLi Wang, et al.
Frontiers in Immunology|February 4, 2020
Endogenous T Cell Receptor Rearrangement Represses Aggressive Central Nervous System Autoimmunity in a TcR-Transgenic Model on the Non-Obese Diabetic BackgroundAsmita Pradeep Yeola, Prenitha Mercy Ignatius Arokia Doss, Joanie Baillargeon, et al.
Journal for Immunotherapy of Cancer|June 20, 2024
Challenges and opportunities in cancer immunotherapy: a Society for Immunotherapy of Cancer (SITC) strategic visionLeisha A Emens, Pedro J Romero, Ana Carrizosa Anderson, et al.
Journal of Translational Medicine|October 29, 2014
Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013Paolo A Ascierto, Antonio M Grimaldi, Ana Carrizosa Anderson, et al.
Pageof 1